Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001195 · ClinicalTrials.gov registry record

Endocrine Studies of Healthy Children

A clinical trial, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
1,247
Enrollment target

NCT00001195: Completed study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00001195 is a clinical trial that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 1,247 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001195 has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
1,247 participants
Enrollment target

Study Summary

Researchers would like to determine normal ranges for hormone levels and to learn more about the genetics involved in hormone production and action. Researchers will take samples of blood, urine, saliva, and stool from healthy children ages 5-17 in order to study different aspects of hormones. Establishing a range of normal hormone levels in children will make diagnosing illnesses with abnormal levels of hormones much easier. Hormone levels in the body can change throughout the day. By collecting samples at different times researchers hope to learn more about the normal daytime and nighttime patterns of hormone secretion. Because some hormone levels change with body size, researchers will also take measurements of patient's body composition. This study will involve children and observe them as inpatients or as outpatients. \<TAB\>

Trial Details

FieldValue
Enrollment Target 1,247 participants
Start Date 1984-08-28
Est. Completion 2014-10-20

What the finished NCT00001195 record still lists

NCT00001195 is an observational study that tracks outcomes without assigning an intervention. Its 1,247 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00001195 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00001195 about?

NCT00001195 is a clinical study titled "Endocrine Studies of Healthy Children". Researchers would like to determine normal ranges for hormone levels and to learn more about the genetics involved in hormone production and action. Researchers will take samples of blood, urine, saliva, and stool from healthy children ages 5-17 in order to study different aspects of hormones. Esta...

What is the current status of trial NCT00001195?

This trial is currently completed. The enrollment target is 1,247 participants. The study started on 1984-08-28. Estimated completion is 2014-10-20.

Who is sponsoring clinical trial NCT00001195?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02743858 · 1,250 participants

    Lymphedema Surveillance Study

  • NCT04670874 · 1,250 participants

    Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

  • NCT04807868 · 1,250 participants

    AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

  • NCT05995821 · 1,250 participants

    Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00001195, the US trial registry maintained by the National Library of Medicine. NCT00001195 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.